uniQure (QURE) Current Taxes (2024 - 2025)
uniQure's (QURE) quarterly Current Taxes came in at $7.8 million in Q3 2025, up 2569.28% quarter-over-quarter from $293000.0 in Q4 2024.
uniQure (QURE) Current Taxes (2024 - 2025) Analysis & Trends
uniQure's Current Taxes history runs 2 years deep, the most recent figure standing at $7.8 million for Q3 2025.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $7.8 million in Q3 2025; TTM through Sep 2025 was $7.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $293000.0, changed N/A from the prior year.
- Current Taxes climbed to $7.8 million in Q3 2025 per QURE's latest filing, from $293000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $7.8 million in Q3 2025 and bottomed at $293000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.82 Mn |
| Dec 31, 2024 | 293,000.00 |